Targeting dormant tumor cells to prevent cancer recurrence von Damen, Maartje P. F., Rheenen, Jacco, Scheele, Colinda L. G. J.

Volltext

Identity and dynamics of mammary stem cells during branching morphogenesis von Scheele, Colinda L. G. J., Hannezo, Edouard, Muraro, Mauro J., Zomer, Anoek, Langedijk, Nathalia S. M., van Oudenaarden, Alexander, Simons, Benjamin D., van Rheenen, Jacco

Volltext

Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers von Derouane, Françoise, Desgres, Manon, Moroni, Camilla, Ambroise, Jérôme, Berlière, Martine, Van Bockstal, Mieke R, Galant, Christine, van Marcke, Cédric, Vara-Messler, Marianela, Hutten, Stefan J, Jonkers, Jos, Mourao, Larissa, Scheele, Colinda L G J, Duhoux, Francois P, Corbet, Cyril

Volltext

Stem cell lineage survival as a noisy competition for niche access von Corominas-Murtra, Bernat, Scheele, Colinda L. G. J., Kishi, Kasumi, Ellenbroek, Saskia I. J., Simons, Benjamin D., van Rheenen, Jacco, Hannezo, Edouard

Volltext

A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis von Li, Li, Ugalde, Alejandro P, Scheele, Colinda L G J, Dieter, Sebastian M, Nagel, Remco, Ma, Jin, Pataskar, Abhijeet, Korkmaz, Gozde, Elkon, Ran, Chien, Miao-Ping, You, Li, Su, Pin-Rui, Bleijerveld, Onno B, Altelaar, Maarten, Momchev, Lyubomir, Manber, Zohar, Han, Ruiqi, van Breugel, Pieter C, Lopes, Rui, Ten Dijke, Peter, van Rheenen, Jacco, Agami, Reuven

Volltext

Corrigendum to “Defining vulnerability in European pregnant women, a Delphi study” [Midwifery 86 (2020) 102708] von Scheele, J., Harmsen van der Vliet–Torij, H.W., Wingelaar-Loomans, E.M., Goumans, M.J.B.M.

Volltext

Non-Innocence of N-Heterocyclic Carbene Ligands: Intermolecular CH Activation in Allyl Palladium NHC Complexes von Scheele, Ulrich J., Dechert, Sebastian, Meyer, Franc

Volltext

A Mammary Organoid Model to Study Branching Morphogenesis von Caruso, Marika, Huang, Sjanie, Mourao, Larissa, Scheele, Colinda L G J

Volltext

Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp); A phase II trial in progress von Paik, P., Sakai, H., Bruns, R., Scheele, J., Straub, J., Felip, E.

Volltext

Defining vulnerability in European pregnant women, a Delphi study von Scheele, J., Harmsen van der Vliet–Torij, H.W., Wingelaar-Loomans, E.M., Goumans, M.J.B.M.

Volltext

Current preconception care practice in the Netherlands — An evaluation study among birth care professionals von Scheele, J., Smith, S.M., Wahab, R.J., Bais, B., Steegers–Theunissen, R.P.M., Gaillard, R., Harmsen van der Vliet - Torij, H.W.

Volltext

Phase II study of tepotinib + gefitinib (TEP+GEF) in MET-positive (MET+)/epidermal growth factor receptor (EGFR)-mutant (MT) non-small cell lung cancer (NSCLC) von Cheng, Y., Zhou, J., Lu, S., Zhang, Y., Zhao, J., Pan, H., Chen, Y.-M., Chian, C.-F., Bruns, R., Johne, A., Scheele, J., Wu, Y.-L.

Volltext

Phase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies von Jurczak, W., Rule, S., Townsend, W., Tucker, D., Sarholz, B., Scheele, J., Gribben, J., Zinzani, P.L.

Volltext

A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study von Paik, P., Cortot, A., Felip, E., Sakai, H., Mazieres, J., Horn, L., Griesinger, F., Bruns, R., Scheele, J., Straub, J., Veillon, R.

Volltext

Combining Pyrazolate and N-Heterocyclic Carbene Coordination Motifs: Synthesis and Characterization of a Double-Crowned Silver Complex von Scheele, Ulrich J, Georgiou, Maria, John, Michael, Dechert, Sebastian, Meyer, Franc

Volltext

Development of a Blueprint for Integrated Care for Vulnerable Pregnant Women von Harmsen van der Vliet-Torij, H. W., Venekamp, A. A., van Heijningen-Tousain, H. J. M., Wingelaar-Loomans, E., Scheele, J., de Graaf, J. P., Lambregtse-van den Berg, M. P., Steegers, E. A. P., Goumans, M. J. B. M.

Volltext

Tepotinib + gefitinib (TEP+GEF) in MET+/epidermal growth factor receptor (EGFR)-mutant non-small lung cancer (NSCLC): Phase II data von Wu, Y.-L., Zhou, J., Lu, S., Zhang, Y., Zhao, J., Pan, H., Chen, Y.-M., Chian, C.-F., Bruns, R., Johne, A., Scheele, J., Cheng, Y.

Volltext

Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data von Sakai, H., Felip, E., Cortot, A.B., Veillon, R., Griesinger, F., Patel, J., Horn, L., Mazieres, J., De Castro Carpeno, J., Morise, M., Sakamoto, T., Bruns, R., Scheele, J., Straub, J., Paik, P.

Volltext

Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program von Geukens, Tatjana, De Schepper, Maxim, Van Den Bogaert, Wouter, Van Baelen, Karen, Maetens, Marion, Pabba, Anirudh, Mahdami, Amena, Leduc, Sophia, Isnaldi, Edoardo, Nguyen, Ha-Linh, Bachir, Imane, Hajipirloo, Maysam, Zels, Gitte, Van Cauwenberge, Josephine, Borremans, Kristien, Vandecaveye, Vincent, Weynand, Birgit, Vermeulen, Peter, Leucci, Eleonora, Baietti, Maria Francesca, Sflomos, George, Battista, Laura, Brisken, Cathrin, Derksen, Patrick W. B., Koorman, Thijs, Visser, Daan, Scheele, Colinda L. G. J., Thommen, Daniela S., Hatse, Sigrid, Fendt, Sarah-Maria, Vanderheyden, Evy, Van Brussel, Thomas, Schepers, Rogier, Boeckx, Bram, Lambrechts, Diether, Marano, Giuseppe, Biganzoli, Elia, Smeets, Ann, Nevelsteen, Ines, Punie, Kevin, Neven, Patrick, Wildiers, Hans, Richard, François, Floris, Giuseppe, Desmedt, Christine

Volltext

Characteristics of older patients with back pain in general practice: BACE cohort study von Scheele, J., Enthoven, W.T.M., Bierma-Zeinstra, S.M.A., Peul, W.C., van Tulder, M.W., Bohnen, A.M., Berger, M.Y., Koes, B.W., Luijsterburg, P.A.J.

Volltext